Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
23M
-
Shares change
-
+8.57M
-
Total reported value, excl. options
-
$600M
-
Value change
-
+$234M
-
Number of buys
-
50
-
Number of sells
-
-20
-
Price
-
$26.14
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2014
74 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q1 2014.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23M shares
of 79.5M outstanding shares and own 28.88% of the company stock.
Largest 10 shareholders include FMR LLC (4.51M shares), BROOKSIDE CAPITAL MANAGEMENT LLC (2.86M shares), CREDIT SUISSE AG/ (2.27M shares), WELLINGTON MANAGEMENT CO LLP (1.46M shares), RA CAPITAL MANAGEMENT, LLC (982K shares), Sectoral Asset Management Inc (948K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (901K shares), JENNISON ASSOCIATES LLC (862K shares), ORBIMED ADVISORS LLC (830K shares), and State Street Corp (693K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.